Skelaxin
Product Images NDC 16590-207

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Skelaxin (NDC 16590-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (2b612c8b 1df9 48f8 880e 7c391449f46a 02)

A line graph illustrating the mean concentrations of metaxalone over 12 hours following an 800 mg dose under fasted and fed conditions. The y-axis shows concentration in ng/mL ranging from 0 to 5000, and the x-axis shows time in hours from 0 to 12. Two lines represent fasted (open circles) and fed (solid circles) states with error bars indicating standard deviation.*

FDA Label Image

Skelaxin 800 mg Label Image (Skelaxin 800 mg Label)

SKELAXIN 800 mg tablet label by STAT Rx USA LLC, distributed by King Pharm Inc. The label shows NDC 16590-207-60 and contains 60 tablets. The active ingredient is Metaxalone 800 mg. Additional details include lot number, sample status, and caution text about drowsiness or dizziness risk.*

FDA Label Image

Chemstructure1 (Skelaxinchemstruc)

Chemical structure of the active ingredient for SKELAXIN, showing a benzene ring with two methyl groups and a connected oxazolidinone ring via an ether and alkyl chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.